9 completed. 9 Phase 3.
By phase and status
Follow Vilazodone: new trials by email Literature Review of Vilazodone trials Research Report on Vilazodone
Trials (filtered) newest first · largest first
All 9 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Vilazodone - Major Depressive Disorder | Phase 3 | Completed | 330 | 2015-05-02 | 2019-09-11 |
Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Vilazodone, Placebo, Fluoxetine - Major Depressive Disorder | Phase 3 | Completed | 473 | 2015-02-28 | 2019-10-01 |
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder Placebo, Vilazodone - Major Depressive Disorder | Phase 3 | Completed | 529 | 2013-07-11 | 2019-12-24 |
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder Placebo, Vilazodone - Generalized Anxiety Disorder | Phase 3 | Completed | 415 | 2013-04-30 | 2019-12-18 |
Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone Vilazodone - Major Depressive Disorder (MDD) | Phase 3 | Completed | 70 | 2012-12-01 | 2015-04-16 |
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder Placebo, Vilazodone - Generalized Anxiety Disorder | Phase 3 | Completed | 680 | 2012-06-30 | 2019-12-18 |
Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) vilazodone, placebo - Major Depressive Disorder | Phase 3 | Completed | 481 | 2008-03-01 | 2010-10-27 |
A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) vilazodone - Major Depressive Disorder | Phase 3 | Completed | 616 | 2007-12-31 | 2017-09-25 |
Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response vilazodone - Depressive Disorder, Major | Phase 3 | Completed | 410 | 2006-02-01 | 2008-02-21 |
Conditions studied
Depressive Disorder, Major (7) · Generalized Anxiety Disorder (2)
Sponsors
Forest Laboratories (7) · Duke University (1) · Genaissance Pharmaceuticals (1)
Countries
United States (9) · Canada (2)
Top investigators
Carol R Reed, MD (2) · Emily McCusker, PhD (2) · Giovanna Forero, MA (2) · Ashwin A Patkar, MD (1) · Carol Reed, M.D. (1) · Chandran Prakash (1)
Results publications
PMID 22106941, PMID 23216998, PMID 24127687, PMID 24940525, PMID 27486544, PMID 29608461, PMID 19284933, PMID 21527122, PMID 21869687, PMID 25891440, PMID 26693034, PMID 27232052, PMID 29633166